Evidence map›Paper›PMID 25599590›Full record

ArticleeLife2015

Phenotypic complementation of genetic immunodeficiency by chronic herpesvirus infection.

Donna A MacDuff, Tiffany A Reese, Jacqueline M Kimmey, Leslie A Weiss, Christina Song, Xin Zhang, Amal Kambal, Erning Duan, Javier A Carrero, Bertrand Boisson and 10 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. LUBAC: a new player in polyglucosan body disease.Biochemical Society transactions · 2021
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Cross-Domain and Viral Interactions in the Microbiome.Microbiology and molecular biology reviews : MMBR · 2019
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 3 countries.

Donna A MacDuffDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, United States.
Tiffany A ReeseDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, United States.
Jacqueline M KimmeyDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, United States.
Leslie A WeissDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, United States.
Christina SongDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, United States.
Xin ZhangDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, United States.
Amal KambalDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, United States.
Erning DuanDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, United States.
Javier A CarreroDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, United States.
Bertrand BoissonHoward Hughes Medical Institute, New York, United States.
Emmanuel LaplantineLaboratory of Molecular Signaling and Cell Activation, Institut Pasteur, Centre National de la Recherche Scientifique, Unité de Recherche Associée, Paris, France.
Alain IsraelLaboratory of Molecular Signaling and Cell Activation, Institut Pasteur, Centre National de la Recherche Scientifique, Unité de Recherche Associée, Paris, France.
Capucine PicardSt Giles Laboratory of Human Genetics of Infectious Disease, Rockefeller University, New York, United States.
Marco ColonnaDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, United States.
Brian T EdelsonDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, United States.
L David SibleyDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, United States.
Christina L StallingsDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, United States.
Jean-Laurent CasanovaHoward Hughes Medical Institute, New York, United States.
Kazuhiro IwaiDepartment of Molecular and Cellular Physiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Herbert W VirginDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, United States.
Washington University in St. Louis · USToxicologie, Pharmacologie et Signalisation Cellulaire · FRUniversité Paris Cité · FRKyoto University · JPRockefeller University · US

Funding

Genetic and Pathway Analysis CoreU19AI109725 · NIAID · WASHINGTON UNIVERSITY · PI ALLEN, PAUL M · 2014 to 2018
$32.7M
Regulation of IgA class switching in the intestinal mucosaP01AI061093 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI CUNNINGHAM-RUNDLES, CHARLOTTE · 2004 to 2021
$29.8M
Transforming Translational Science and Education to Benefit Human HealthUL1TR000043 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY · 2012 to 2015
$26.8M
TRAINING PROGRAM IN CELLULAR AND MOLECULAR BIOLOGYT32GM007067 · NIGMS · WASHINGTON UNIVERSITY · PI TRUE-KROB, HEATHER L · 1985 to 2020
$20.4M
Molecular Basis of Human ToxoplasmosisR01AI118426 · NIAID · WASHINGTON UNIVERSITY · PI SIBLEY, L. DAVID · 2015 to 2024
$6.0M
MOLECULAR BASIS OF TOXOPLASMOSIS IN AIDS PATIENTSR01AI036629 · NIAID · WASHINGTON UNIVERSITY · PI SIBLEY, L. DAVID · 1994 to 2013
$5.3M
IMMUNITY TO INTRACELLULAR PATHOGENSR01AI062832 · NIAID · WASHINGTON UNIVERSITY · PI UNANUE, EMIL RAPHAEL · 2005 to 2014
$3.7M
SUSCEPTIBILILTY GENE-VIRUS INTERACTIONS IN INFLAMMATORY BOWEL DISEASER01AI084887 · NIAID · WASHINGTON UNIVERSITY · PI STAPPENBECK, THADDEUS S, VIRGIN, HERBERT W · 2010 to 2014
$1.9M
NCATS NIH HHS 8UL1TR000043NCATS NIH HHS UL1 TR000043NIAID NIH HHS 5P01 AI061093NIAID NIH HHS AI036629NIAID NIH HHS AI062832NIAID NIH HHS P01 AI061093NIAID NIH HHS R01 AI036629NIAID NIH HHS R01 AI062832NIAID NIH HHS R01 AI084887NIAID NIH HHS R01 AI118426NIAID NIH HHS U19 AI109725NIGMS NIH HHS GM007067NIGMS NIH HHS T32 GM007067
6 · The paper itself

Abstract

Variation in the presentation of hereditary immunodeficiencies may be explained by genetic or environmental factors. Patients with mutations in HOIL1 (RBCK1) present with amylopectinosis-associated myopathy with or without hyper-inflammation and immunodeficiency. We report that barrier-raised HOIL-1-deficient mice exhibit amylopectin-like deposits in the myocardium but show minimal signs of hyper-inflammation. However, they show immunodeficiency upon acute infection with Listeria monocytogenes, Toxoplasma gondii or Citrobacter rodentium. Increased susceptibility to Listeria was due to HOIL-1 function in hematopoietic cells and macrophages in production of protective cytokines. In contrast, HOIL-1-deficient mice showed enhanced control of chronic Mycobacterium tuberculosis or murine γ-herpesvirus 68 (MHV68), and these infections conferred a hyper-inflammatory phenotype. Surprisingly, chronic infection with MHV68 complemented the immunodeficiency of HOIL-1, IL-6, Caspase-1 and Caspase-1;Caspase-11-deficient mice following Listeria infection. Thus chronic herpesvirus infection generates signs of auto-inflammation and complements genetic immunodeficiency in mutant mice, highlighting the importance of accounting for the virome in genotype-phenotype studies.

Indexed as

Acute DiseaseAnimalsBone Marrow CellsCaspase 1Cell CompartmentationChronic DiseaseCitrobacterCytokinesGenetic Complementation TestHerpesviridaeHerpesviridae InfectionsHumansImmunity, InnateImmunologic Deficiency SyndromesInflammationInflammation MediatorsCaspase 1CytokinesInflammation MediatorsInterleukin-6Ubiquitin-Protein Ligasesimmunodeficiencyimmunologyinfectious diseaselinear ubiquitinationListeria monocytogenesmicrobiologymousemurine gamma-herpesvirus 68NF-kappaB

Identifiers

PMID25599590
PMCPMC4298697
OpenAlexW2148468408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.